A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH

Views
A ...1121

Total Visits Per Month

August 2023September 2023October 2023November 2023December 2023January 2024February 2024
A ...13418203813

File Visits

Views
29FL5e9GFDkgQ.pdf393